Joshua A. Levine - Concepedia

Author

Joshua A. Levine

Eli Lilly (United States)ORCID

Also Known As

J Levine, J. Levine, J.A. Levine, JOSHUA A. LEVINE, Joshua A Levine, Joshua A. Levine, Joshua Levine, Levine, Joshua

Publications

464

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Northwestern University Trillium Health Centre Eli Lilly (Ireland)Jesse Brown VA Medical Center

About

Joshua A. Levine is an author at Eli Lilly (United States) specializing in cell signaling, self-tolerance, and natural killer cells.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	15
2	Cell Biology	1	1	15
3	Immunology	1	1	15
4	Cell Development	1	1	15
5	Cell Signaling	1	1	15

Joshua A. Levine

Publications

380

Citations

H-Index

Page 1

	Year	Citations
Role of PAI-1 in hepatic steatosis and dyslipidemia Joshua A. Levine, Carlota Oleaga, Mesut Eren, Scientific Reports	2021	101
High‐resolution NMR spectroscopic trends and assignment rules of metal‐free, metallated and substituted corroles Yael S. Balazs, Irena Saltsman, Atif Mahammed, Magnetic Resonance in Chemistry	2004	76
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison Karan Vadher, Hiren Patel, Reema Mody, Diabetes Obesity and Metabolism	2022	51
Predictors of ≥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1–4 Maciej T. Małecki, Rachel L. Batterham, Naveed Sattar, Diabetes Care	2023	43
Prenatal Androgen Treatment Alters Body Composition and Glucose Homeostasis in Male Rats Miloš Lazić, Fraser Aird, Joshua A. Levine, Journal of Endocrinology	2010	31
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A <i>post hoc</i> analysis of the <scp>SURPASS</scp> ‐1 to ‐5 studies Ildiko Lingvay, Alice Cheng, Joshua A. Levine, Diabetes Obesity and Metabolism	2022	29
Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain Vladimir Abarinov, Joshua A. Levine, Angela J. Churchill, Genes & Development Innate Immune SystemImmunologyImmunologic Mechanismβ Cell PerformanceInnate Immunity	2023	15
Inhibition of PAI‐1 Promotes Lipolysis and Enhances Weight Loss in Obese Mice Joshua A. Levine, Shantel Olivares, Toshio Miyata, Obesity	2021	13
Efficacy and Safety of Tirzepatide in Adults With Type 2 Diabetes: A Perspective for Primary Care Providers Pamela Kushner, John E. Anderson, J. Simon, Clinical Diabetes	2022	11
Dapagliflozin-Induced Acute-on-Chronic Liver Injury Joshua A. Levine, Amisha Wallia, Melinda Rogers, ACG Case Reports Journal	2016	10

Page 1